Review compiles LL-37's diverse antimicrobial effects and immune modulation, highlighting clinical potential.
LL-37 has attracted significant research attention as a multifunctional antimicrobial peptide which is implicated in a broad spectrum of activities. It is the only human cathelicidin and represents a key molecule in host defense. Hence, it is described as possessing antimicrobial activity against a wide range of pathogens, including Gram-negative and Gram-positive bacteria, numerous viral species, and various fungi. Though it is widely recognized for its direct antimicrobial activity, it is a multifaceted immunomodulatory and tissue-protective molecule. Beyond host defense, LL-37 actively regulates inflammatory signaling, cellular interactions within the immune system, and mechanisms of tissue repair. Its ability to fine-tune immune responses and simultaneous regeneration highlights its dual role in inflammation control and wound healing. These pleiotropic functions place LL-37 in the spotlight between innate immunity and tissue homeostasis. This review aims to compile LL-37’s antimicrobial and immunomodulatory activities and highlight its wide range of potential clinical applications.
No takes yet. Share an insight, caveat, or question.
Tzortzis et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: